Sabra Health Care REIT, Inc.
SBRA
NASDAQ·Real Estate·REIT - Healthcare Facilities·Mkt cap $5.2B
$20.78
▼ -0.72%
P/E
57.34
Mkt Cap
$5.2B
52-Wk Range
$17.17–$22.77
52-Week Range
$17.17 - $22.77
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 8.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Diversified portfolio across five healthcare property types reduces tenant and revenue concentration risk
- Large-scale operations with 41,445 beds/units providing economies of scale and operational efficiency
- Geographic diversification across United States and Canada markets
- Established relationships with leading healthcare operators and property managers
- REIT structure providing tax-efficient income distribution and access to capital markets
Bear Case
1 risk
- Low volatility (beta 0.6).
Growth
Stable outlook
Aging U.S. and Canadian populations increasing demand for senior housing and skilled nursing care
Value
Fairly valued vs Healthcare REITs peers
Momentum
Strong
+14.4% over 3m
Quality
Excellent
Solid business
Dividend
High yield
5.77% yield
Smart-money signal
Who's buying SBRA right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
AUG 3, 2026
Reported EPS of -$0.10 vs $0.17 consensus (-158.4% surprise). Revenue of $235.9M vs $219.4M expected (+7.5%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-158.4%
Revenue trend · last 8Q
—
+12%
+10%
+7%
+7%
+16%
+21%
+25%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$178.0M
$182.3M
$183.5M
$189.2M
$190.0M
$211.9M
$221.8M
$235.9M
Margins · last 8Q
Gross
0.0%
Operating
0.0%
Profit
-11.1%
Wall Street consensus
9 analysts · 33% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
33%
Hold
67%
Sell
0%
Median Price Target
—
Latest: Barclays · Aug 31, 2026
vs Industry
How SBRA stacks vs REIT - Healthcare Facilities
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related